| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.058 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |